ventricular septal defect_Vcan<tm2Hwat>/Vcan<tm2Hwat>

http://metadb.riken.jp/0010402I129BALBcC57BL6Vcantm2HwatVcantm2HwatVcantm2Hwat

ventricular septal defect_Vcan<tm2Hwat>/Vcan<tm2Hwat>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• versican
  http://metadb.riken.jp/db/mgi_rdf/MGI:102889

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Vcan<tm2Hwat>/Vcan<tm2Hwat>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Vcan<tm2Hwat>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129 * BALB/c * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• ventricular septal defect
  http://purl.obolibrary.org/obo/MP_0010402

文献

http://purl.org/net/cito/citesAsAuthority

• Sonoko. Hatano, et.al., Versican/PG-M is essential for ventricular septal formation subsequent to cardiac atrioventricular cushion development., Glycobiology, 2012, 22
  http://rdf.ncbi.nlm.nih.gov/pubmed/22692047